-+ 0.00%
-+ 0.00%
-+ 0.00%

PARABILIS MEDICINES - TO DISCLOSE ADDITIONAL FAP DATA FROM PHASE 1/2 TRIAL IN Q1 2027

Reuters·10/14/2026 11:00:02

Please log in to view news